← Back to Clinical Trials
Recruiting NCT06603350

NCT06603350 The Effect of Perioperative Factors on Postoperative Outcomes After Lung Transplantation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06603350
Status Recruiting
Phase
Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Condition Postoperative Complications After Lung Transplantation
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2024-07-28
Primary Completion 2026-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
No intenvention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2024-07-28 with a primary completion date of 2026-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

1. Evaluate the influence of perioperative factors on postoperative outcomes in patients undergoing lung transplantation patients. 2. To evaluate the feasibility of using pulmonary ultrasound to identify lung complications such as atelectasis and pulmonary edema after lung transplantation 3. Observe the changes of perioperative inflammation and immune indexes after lung transplantation

Eligibility Criteria

Inclusion Criteria: Prosedure of lung transplantation, Aged more than 18 years old Exclusion Criteria: Secondary lung transplantation, multiple organ transplantation, refusal to participate

Frequently Asked Questions

Who can join the NCT06603350 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Postoperative Complications After Lung Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06603350 currently recruiting?

Yes, NCT06603350 is actively recruiting participants. Visit ClinicalTrials.gov or contact Second Affiliated Hospital, School of Medicine, Zhejiang University to inquire about joining.

Where is the NCT06603350 trial being conducted?

This trial is being conducted at Hangzhou, China.

Who is sponsoring the NCT06603350 clinical trial?

NCT06603350 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology